Exact Mass: 363.1576

Exact Mass Matches: 363.1576

Found 58 metabolites which its exact mass value is equals to given mass value 363.1576, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

   

(-)-Spirotriprostatin

(-)-Spirotriprostatin

C21H21N3O3 (363.1583)


   
   
   
   
   

alpha-Naucleonidine

alpha-Naucleonidine

C21H21N3O3 (363.1583)


   
   
   
   
   

C21H21N3O3_8,8-Dimethyl-5a,6-dihydro-3H,5H,8H-spiro[indole-2,7-pyrrolo[1,2:4,5]pyrazino[1,2-a]azepine]-3,5,12(1H,2H)-trione

NCGC00380729-01_C21H21N3O3_8,8-Dimethyl-5a,6-dihydro-3H,5H,8H-spiro[indole-2,7-pyrrolo[1,2:4,5]pyrazino[1,2-a]azepine]-3,5,12(1H,2H)-trione

C21H21N3O3 (363.1583)


   

Cys Gly Gly Lys

(2S)-6-amino-2-(2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}acetamido)hexanoic acid

C13H25N5O5S (363.1576)


   

Cys Gly Lys Gly

2-[(2S)-6-amino-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}hexanamido]acetic acid

C13H25N5O5S (363.1576)


   

Cys Lys Gly Gly

2-{2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]acetamido}acetic acid

C13H25N5O5S (363.1576)


   

Gly Cys Gly Lys

(2S)-6-amino-2-{2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]acetamido}hexanoic acid

C13H25N5O5S (363.1576)


   

Gly Cys Lys Gly

2-[(2S)-6-amino-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]hexanamido]acetic acid

C13H25N5O5S (363.1576)


   

Gly Gly Cys Lys

(2S)-6-amino-2-[(2R)-2-[2-(2-aminoacetamido)acetamido]-3-sulfanylpropanamido]hexanoic acid

C13H25N5O5S (363.1576)


   

Gly Gly Lys Cys

(2R)-2-[(2S)-6-amino-2-[2-(2-aminoacetamido)acetamido]hexanamido]-3-sulfanylpropanoic acid

C13H25N5O5S (363.1576)


   

Gly Lys Cys Gly

2-[(2R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-sulfanylpropanamido]acetic acid

C13H25N5O5S (363.1576)


   

Gly Lys Gly Cys

(2R)-2-{2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]acetamido}-3-sulfanylpropanoic acid

C13H25N5O5S (363.1576)


   

Lys Cys Gly Gly

2-{2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]acetamido}acetic acid

C13H25N5O5S (363.1576)


   
   

Lys Gly Cys Gly

2-[(2R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-sulfanylpropanamido]acetic acid

C13H25N5O5S (363.1576)


   

Lys Gly Gly Cys

(2R)-2-(2-{2-[(2S)-2,6-diaminohexanamido]acetamido}acetamido)-3-sulfanylpropanoic acid

C13H25N5O5S (363.1576)


   
   
   
   
   
   
   

pyridine, 1-oxide-4-ethenyl-, homopolymer

pyridine, 1-oxide-4-ethenyl-, homopolymer

C21H21N3O3 (363.1583)


   

Ozenoxacin

Ozenoxacin

C21H21N3O3 (363.1583)


D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors

   

Protuboxepin B

Protuboxepin B

C21H21N3O3 (363.1583)


An organic heterotricyclic compound that is 10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione substituted by a benzyl group at position 8 and an isopropyl group at position 11. It has been isolated from Aspergillus species.

   

6-(1,3-benzodioxol-5-yl)-N-(3-oxanylmethyl)-4-quinazolinamine

6-(1,3-benzodioxol-5-yl)-N-(3-oxanylmethyl)-4-quinazolinamine

C21H21N3O3 (363.1583)


   

(9S,11R)-12,12-dimethylspiro[1,7-diazatricyclo[7.5.0.03,7]tetradeca-3,13-diene-11,2-1H-indole]-2,3,8-trione

(9S,11R)-12,12-dimethylspiro[1,7-diazatricyclo[7.5.0.03,7]tetradeca-3,13-diene-11,2-1H-indole]-2,3,8-trione

C21H21N3O3 (363.1583)


   

6-(1,3-benzodioxol-5-yl)-N-(2-oxanylmethyl)-4-quinazolinamine

6-(1,3-benzodioxol-5-yl)-N-(2-oxanylmethyl)-4-quinazolinamine

C21H21N3O3 (363.1583)


   

[(1-amino-2-naphthalen-1-ylethylidene)amino] N-(2-ethoxyphenyl)carbamate

[(1-amino-2-naphthalen-1-ylethylidene)amino] N-(2-ethoxyphenyl)carbamate

C21H21N3O3 (363.1583)


   
   
   
   
   
   
   

E1231

E1231

C21H21N3O3 (363.1583)


E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1]. E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE-/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases[1].

   

2-hydroxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecan]-3'-ene-2',8'-dione

2-hydroxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecan]-3'-ene-2',8'-dione

C21H21N3O3 (363.1583)


   

5-hydroxy-6-[(4-hydroxyphenyl)methyl]-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-dihydropyrazin-2-one

5-hydroxy-6-[(4-hydroxyphenyl)methyl]-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-dihydropyrazin-2-one

C21H21N3O3 (363.1583)


   

(4s,7r)-7-benzyl-6-hydroxy-4-isopropyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

(4s,7r)-7-benzyl-6-hydroxy-4-isopropyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C21H21N3O3 (363.1583)


   

methyl 14-(hydroxymethyl)-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15(20),16,18-heptaene-19-carboxylate

methyl 14-(hydroxymethyl)-3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15(20),16,18-heptaene-19-carboxylate

C21H21N3O3 (363.1583)


   

(3s,6's,9's)-2-hydroxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecan]-3'-ene-2',8'-dione

(3s,6's,9's)-2-hydroxy-6'-(2-methylprop-1-en-1-yl)-1',7'-diazaspiro[indole-3,5'-tricyclo[7.3.0.0³,⁷]dodecan]-3'-ene-2',8'-dione

C21H21N3O3 (363.1583)


   

(9's)-12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-3',13'-diene-2',3,8'-trione

(9's)-12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-3',13'-diene-2',3,8'-trione

C21H21N3O3 (363.1583)


   

12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-3',13'-diene-2',3,8'-trione

12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-3',13'-diene-2',3,8'-trione

C21H21N3O3 (363.1583)


   

(2s,9's)-12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-3',13'-diene-2',3,8'-trione

(2s,9's)-12',12'-dimethyl-1h-1',7'-diazaspiro[indole-2,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-3',13'-diene-2',3,8'-trione

C21H21N3O3 (363.1583)


   

6,7-dimethoxy-4-(4-methoxyphenyl)-1-methyl-3h-naphtho[2,3-d]imidazol-2-imine

6,7-dimethoxy-4-(4-methoxyphenyl)-1-methyl-3h-naphtho[2,3-d]imidazol-2-imine

C21H21N3O3 (363.1583)


   

n-(2-{2-[1-(dimethylamino)-2-phenylethyl]-1,3-oxazole-5-carbonyl}phenyl)carboximidic acid

n-(2-{2-[1-(dimethylamino)-2-phenylethyl]-1,3-oxazole-5-carbonyl}phenyl)carboximidic acid

C21H21N3O3 (363.1583)


   

7-benzyl-6-hydroxy-4-isopropyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

7-benzyl-6-hydroxy-4-isopropyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C21H21N3O3 (363.1583)


   

(3s,6s)-5-hydroxy-6-[(4-hydroxyphenyl)methyl]-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-dihydropyrazin-2-one

(3s,6s)-5-hydroxy-6-[(4-hydroxyphenyl)methyl]-3-(1h-indol-3-ylmethyl)-1-methyl-3,6-dihydropyrazin-2-one

C21H21N3O3 (363.1583)


   

(1r,2r,4s,5r,7r,12r,15s,23r)-4-amino-18-methoxy-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-10,17(22),18,20-tetraen-3-one

(1r,2r,4s,5r,7r,12r,15s,23r)-4-amino-18-methoxy-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-10,17(22),18,20-tetraen-3-one

C21H21N3O3 (363.1583)